Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study

2010386 citationsJournal Article

Authors

Good health and well-being

Published in: Ophthalmology

Volume 118, Issue 5, pp. 831-839

Field-Weighted Citation Impact: 23.94